Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole Step up vs Conventional Protocol for Ovulation Induction in PCOS
NCT07143682Phase 3Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jan 2023
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of letrozole in polycystic ovary syndrome (PCOS) and infertility (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoints: Number of participants having mature follicle at 3 months and Number of participants having adequate endometrial thickness at 3 months. Started Jan 2023; status: completed.
02
Drugs
letrozole
03
Conditions
polycystic ovary syndrome (PCOS)infertility
Beyond the preview
Go deeper on NCT07143682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07143682.